Skip to main content
R&D

Looking back on 2018 and looking ahead to 2019 in R&D

4 certified projects in 2018, new calls in 2019 and a training course created by the 6 clusters

2018 was a good year for cluster projects with six projects submitted to the Walloon region, including one supported by BioWin and MecaTech.

Four were certified for a total sum of 11.3 million euros, 7.8 million euros of which in subsidies. 

  • CQIntégré 

CQIntégré is run by Trasis and comes under the topic radiations applied to health. In partnership with Taipro and two academic laboratories of the ULB (nuclear medicine service, TEP unit) and the UCL (ELEN Department), the consortium aims to develop an integrated and compact system dedicated to quality control (QC) of radioactive pharmaceutical products used in nuclear medicine procedures. The budget allocated for this 36 month project is €2.7 million.

  • BENEFIT

BENEFIT (Biostatistical Estimation of Net Effects for Individualization of Therapy) is joining the "biopharma and data science" topics. Coordinated by IDDI, the project is aiming to develop a new statistical method (Generalised Pairwise Comparisons) and to create software for designing and analysing clinical trials using this innovative approach which will be of interest to all stakeholders, including patients. To successfully complete this 30-month project with a budget of €1.8 million, IDDI is collaborating with four other partners: Brystol-Myers Squibb, UCL (Institute of biostatistics and actuarial sciences), EORTC and the University Hospital of Lyon.

  • IonCath

The IonCath project also belongs to the "biopharma and data sciences" topics. It aims to develop a new intravascular balloon catheter. This device aims to use iontophoresis for the very localized release of an active substance to treat patients with arterial stenosis in the legs.
Nexeon MedSystems Belgium, the project’s coordinator, has called upon the expertise of MediLine, the CER Group, the Louvain Drug Research Institute and the Bio & Soft Matter laboratory at Louvain Catholic University, and the Liège University Hospital Cardiology Unit. The project has a budget of €3.47 million and will last four years.

  • eLISA

The eLISA project (medical devices) aims to develop a treatment device for sleep apnea that is light, connected and accessible to all. eLISA is a 4-year project, benefiting from the financial support of the Walloon Region as part of a research and development project of BioWin Health, for a total budget of 3.2 million euros.  Neoma Labs is the coordinator of the project, and the other three partners are Quimesis, the Catholic University of Louvain (UCL) and the University of Namur (The naXys Institute).

Four were certified for a total sum of 11.3 million euros, 7.8 million euros of which in subsidies

A MecaTech project supported by BioWin:

ArcPT (radiations applied to health) has been certified by the MecaTech cluster and is also backed by BioWin. More information

Go/No-Go:

What’s more, the BioCloud4.0 (bioproduction) and Prouesse (medical devices) projects successfully passed the Go/No Go milestone imposed by the Region and the Walloon Government Jury.

Process:

Lastly, the cluster proposed adapting the process for setting up and evaluating projects to make the screening more consistent and efficient and shorten certification waiting times. 

Perspectives 2019

In 2019, the cluster is launching two calls for projects and strongly encouraging proposals involving artificial intelligence.

The operational unit also worked with the R&D teams of the six clusters, led by GreenWin, to design a two-day training course on setting up and following up on collaborative research and development projects. The first day of training on January 24th had over 30 attendees. The second will take place on February 5, 2019.